Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Colorectal Neoplasms

medroxyprogesterone acetate has been researched along with Colorectal Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, G; Aragaki, AK; Beresford, SA; Cauley, JA; Chlebowski, RT; Eaton, CB; Gass, M; Howard, BV; Hsia, J; Jackson, RD; Johnson, KC; Kooperberg, C; Kuller, LH; LaCroix, AZ; Lewis, CE; Limacher, M; Liu, S; Manson, JE; Margolis, KL; Martin, LW; O'Sullivan, MJ; Ockene, JK; Powell, LH; Prentice, RL; Rossouw, JE; Simon, MS; Stefanick, ML; Thomson, CA; Van Horn, L; Vitolins, MZ; Wactawski-Wende, J; Wallace, RB; Wassertheil-Smoller, S1
Aedo, S; Barriga, P; Blümel, JE; Brantes, S; Campodónico, Í; Cavada, G; Chedraui, P; Fica, J; Irribarra, C; Vallejo, M1
Allison, M; Anderson, GL; Brzyski, R; Jackson, RD; Johnson, KC; Kuller, LH; Lane, DS; Langer, RD; Manson, JE; Ockene, J; Pettinger, M; Prentice, RL; Rossouw, JE; Sarto, G; Wactawski-Wende, J1
Chlebowski, RT; Hubbell, FA; Johnson, KC; Kato, I; Muskovitz, A; Prentice, RL; Simon, MS; Wactawski-Wende, J; Young, A1
Anderson, GL; Beresford, SA; Howard, BV; Jackson, RD; Johnson, KC; Kooperberg, C; Kotchen, JM; LaCroix, AZ; Ockene, J; Prentice, RL; Rossouw, JE; Stefanick, ML1
Enserink, M1
Heinemann, V; Parhofer, K1
Adams-Campbell, LL; Ascensao, J; Chen, C; Chlebowski, RT; Harris, R; Hubbell, FA; Ritenbaugh, C; Rodabough, RJ; Rosenberg, CA; Taylor, VM; Wactawski-Wende, J; White, E1

Trials

6 trial(s) available for medroxyprogesterone acetate and Colorectal Neoplasms

ArticleYear
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
    JAMA, 2013, Oct-02, Volume: 310, Issue:13

    Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Pulmonary Embolism; Quality of Life; Risk; Stroke; Treatment Outcome; United States

2013
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
    American journal of epidemiology, 2009, Jul-01, Volume: 170, Issue:1

    Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Contraceptive Agents, Female; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progestins; Pulmonary Embolism; Retrospective Studies; Risk Factors; Stroke; Survival Rate; Thrombosis; Time Factors; Washington

2009
Estrogen plus progestin and colorectal cancer incidence and mortality.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-10, Volume: 30, Issue:32

    Topics: Adult; Aged; Colorectal Neoplasms; Delayed Diagnosis; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Odds Ratio; Progestins; Research Design; Risk Assessment; Risk Factors; Sample Size; United States; Women's Health

2012
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    JAMA, 2002, Jul-17, Volume: 288, Issue:3

    Topics: Aged; Breast Neoplasms; Clinical Trials Data Monitoring Committees; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk; Stroke; Survival Analysis; Thrombosis; Treatment Outcome

2002
[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study].
    Der Internist, 2003, Volume: 44, Issue:7

    Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk Assessment; Stroke; Survival Analysis; Thrombosis; Treatment Outcome; United States; Women's Health

2003
Estrogen plus progestin and colorectal cancer in postmenopausal women.
    The New England journal of medicine, 2004, Mar-04, Volume: 350, Issue:10

    Topics: Aged; Colorectal Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Postmenopause; Uterine Hemorrhage

2004

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Colorectal Neoplasms

ArticleYear
Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.
    Menopause (New York, N.Y.), 2015, Volume: 22, Issue:12

    Topics: Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Monte Carlo Method; Placebos; Proportional Hazards Models; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Survival Rate; Women's Health

2015
Women's health. The vanishing promises of hormone replacement.
    Science (New York, N.Y.), 2002, Jul-19, Volume: 297, Issue:5580

    Topics: Breast Neoplasms; Cardiovascular Diseases; Colorectal Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Menopause; Postmenopause; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Selection Bias; Time Factors

2002
Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    Ginecologia y obstetricia de Mexico, 2002, Volume: 70

    Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors; Venous Thrombosis

2002